Supplemental material
Bioengineered
Volume 13, 2022 - Issue 2
Open access
1,236
Views
2
CrossRef citations to date
0
Altmetric
Research Paper
Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia
Yabo LiuDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaView further author information
, Huibo LiDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaView further author information
, Yanqiu ZhaoDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaView further author information
, Dandan LiDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaView further author information
, Qian ZhangDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaView further author information
, Jinyue FuDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaView further author information
& Shengjin FanDepartment of Hematology, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang, ChinaCorrespondence[email protected]
https://orcid.org/0000-0002-6772-5060View further author information
Pages 2296-2307
|
Received 13 Oct 2021, Accepted 27 Dec 2021, Published online: 16 Jan 2022
Related Research Data
Knockdown of ADORA2A antisense RNA 1 inhibits cell proliferation and enhances imatinib sensitivity in chronic myeloid leukemia
Source:
Taylor & Francis
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.